Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 233

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer

Open access
Lieu, Christopher H., Golemis, Erica A., Serebriiskii, Ilya G., Newberg, Justin, Hemmerich, Amanda, Connelly, Caitlin, Messersmith, Wells A., Eng, Cathy, Eckhardt, S. Gail, Frampton, Garrett, Cooke, Matthew, Meyer, Joshua E. · 2019 · Clinical Cancer Research

Abstract

Purpose: The incidence rates of colorectal cancers are increasing in young adults. The objective of this study was to investigate genomic differences between tumor samples collected from younger and older patients with colorectal cancer. Experimental Design: DNA was extracted from 18,218 clinical specimens, followed by hybridization capture of 3,769 exons from 403 cancer-related genes and 47 introns of 19 genes commonly rearranged in cancer. Genomic alterations (GA) were determined, and association with patient age and microsatellite stable/microsatellite instability high (MSS/MSI-H) status established. Results: Overall genomic alteration rates in the younger (<40) and older (≥50) cohorts were similar in the majority of the genes analyzed. Gene alteration rates in the microsatellite stable (MSS) younger and older cohorts were largely similar, with several notable differences. In particular, TP53 (FDR < 0.01) and CTNNB1 (FDR = 0.01) alterations were more common in younger patients with colorectal cancer, and APC (FDR < 0.01), KRAS (FDR < 0.01), BRAF (FDR < 0.01), and FAM123B (FDR < 0.01) were more commonly altered in older patients with colorectal cancer. In the MSI-H cohort, the majority of genes showed similar rate of alterations in all age groups, but with significant differences seen in APC (FDR < 0.01), BRAF (FDR < 0.01), and KRAS (FDR < 0.01). Conclusions: Tumors from younger and older patients with colorectal cancer demonstrated similar overall rates of genomic alteration. However, differences were noted in several genes relevant to biology and response to therapy. Further study will need to be conducted to determine whether the differences in gene alteration rates can be leveraged to provide personalized therapies for young patients with early-onset sporadic colorectal cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-19-0899

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 233

Metadata

Authors
Lieu, C. H., Golemis, E. A., Serebriiskii, I. G., Newberg, J., Hemmerich, A., Connelly, C., Messersmith, W. A., Eng, C., Eckhardt, S. G., Frampton, G., Cooke, M., & Meyer, J. E.
Venue
Clinical Cancer Research
Published
2019-10-01
Volume
25
Issue
19
Pages
5852-5858
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2953900933
Cited by
233
References
10
FWCI
12.68
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-19-0899
The paper
Lieu, C. H., Golemis, E. A., Serebriiskii, I. G., Newberg, J., Hemmerich, A., Connelly, C., Messersmith, W. A., Eng, C., Eckhardt, S. G., Frampton, G., Cooke, M., & Meyer, J. E. (2019). Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-19-0899

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.